-
Featured
New Strategies for Heart Failure Patients Improves Outcomes
One-third of heart failure patients do not respond to cardiac resynchronization therapy (CRT) | A coordinated care approach at Mass General for heart failure patients improves outcomes.
-
Featured
The Promise of Ventricular-Assist Devices (VADs)
VAD technology is continually improving. Mass General data indicates new VADs improve 5-year survival rates. Trials for the latest generation are under way.
-
Using the Framingham Heart Study to Understand Heart Failure
In this video, Matthew Nayor, MD, cardiologist in the Heart Failure and Transplantation Program in the Corrigan Minehan Heart Center, discusses his research on identifying and predicting heart failure using data from the Framingham Heart Study to understand protein measurements in blood.
-
Vericiguat Cuts Hospital Admissions in HFrEF Patients
The recent VICTORIA trial found that the novel oral agent vericiguat reduced mortality and hospitalization among recently decompensated heart failure with reduced ejection fraction (HFrEF) patients. The trial is the first to lower the risk of heart failure hospitalization in HFrEF patients.
-
Obesity Linked to Improved Survival of Patients with Pulmonary Hypertension
Akin to the "obesity paradox" described in heart failure, Massachusetts General Hospital researchers find that obesity in patients with pulmonary hypertension is associated with reduced mortality.
-
Percutaneous Valve Replacement Therapy Sometimes an Option During Pregnancy
According to Massachusetts General Hospital clincians, percutaneous balloon mitral valvuloplasty is now the treatment of choice when mitral valve repair is indicated during pregnancy, and catheter-based procedures are being tried for treatment of aortic stenosis in pregnant women.
Heart Failure contributors
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
Vericiguat Cuts Hospital Admissions in HFrEF Patients
-
Thoralf M. Sundt, MD
Chief, Division of Cardiac Surgery, Director, Corrigan Minehan Heart Center
Recent Article
Outcomes of Elective Cardiac Surgery at Mass General Not Affected by Start Time
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
